Andreas M Kaufmann, PhD, of Gynecologic Tumor Immunology and HPV Laboratory at the Department for Gynecology at Charité-Universitaetsmedizin Berlin, Germany

"As a research laboratory we are looking for simple and robust test systems that give a multitude of information on a sample and in an observer independent and unbiased way. We have used the SimpliPlex Breast Cancer multiplex test from Omnigene on breast biopsy FFPE samples from our collaboration partners in sub-saharan Africa. Pathological diagnoses are sometimes difficult to obtain timely and accurate in LMIC but also in HIC. There may be delays and interobserver variations as microscopical images are more difficult to quantify and to standardize. The clinical impact on patient therapy can only be estimated. A molecular method like a multiplexed, quantitative expression measurement as it is obtained by this innovative approach and technology can ameliorate problems of misdiagnosis and observer-dependent interpretation. Since processing is simple, standardized and high-throughput and interpretation is unbiased I regard this technology an example of a breakthrough development for patient care."